Literature DB >> 33550476

LncRNA FEZF1-AS1 accelerates the migration and invasion of laryngeal squamous cell carcinoma cells through miR-4497 targeting GBX2.

Xudong Chen1, Peng Cheng2, Cihao Hu2.   

Abstract

BACKGROUND: MiR-4497 has been previously proved to exert an anti-cancer role in laryngeal squamous cell carcinoma (LSCC) by negatively regulating gastrulation brain homeobox 2 (GBX2). However, the mechanism of miR-4497 in LSCC has yet to be fully elucidated. This study intended to investigate the role of FEZF1-AS1 in the migration and invasion of LSCC cells and clarified its mechanism through miR-4497 and GBX2.
METHODS: qPCR evaluated the expression of FEZF1-AS1, miR-4497 and GBX2 in LSCC tissues and cells, compared with controls. Western blotting analyzed GBX2, E-cadherin, N-cadherin and Vimentin. CCK8, wound healing and transwell assays assessed the viability, migration and invasion of TU686 and UM-SCC-17A cells. Luciferase reporter assay affirmed the interplay of miR-4497 with FEZF1-AS1 or GBX2 and Pearson's correlation analysis explored the association between each two genes in both tumor and non-tumor tissues.
RESULTS: FEZF1-AS1 was highly expressed in LSCC tissues and cells. Silence or elevation of FEZF1-AS1 inhibited or promoted the migration and invasion of TU686 and UM-SCC-17A cells. FEZF1-AS1 targeted and negatively modulated miR-4497. Inhibition of miR-4497 markedly restored the FEZF1-AS1 silence-repressed cell viability of TU686 and UM-SCC-17A cells. Further, FEZF1-AS1 could positively regulate GBX2 via negative regulation of miR-4497. In these two cells, GBX2 deficiency reversed the promoting impacts of miR-4497 repression on migration and invasion.
CONCLUSION: Taken together, FEZF1-AS1, heightened in LSCC tissues and cells, promotes cell migration and invasion of LSCC cells via targeting miR-4497 that inhibits GBX2. The finding may offer new options for the treatment of this cancer.

Entities:  

Keywords:  FEZF1-AS1; GBX2; Invasion; Laryngeal squamous cell carcinoma; Migration; miR-4497

Mesh:

Substances:

Year:  2021        PMID: 33550476     DOI: 10.1007/s00405-021-06636-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  27 in total

Review 1.  An update on larynx cancer.

Authors:  Conor E Steuer; Mark El-Deiry; Jason R Parks; Kristin A Higgins; Nabil F Saba
Journal:  CA Cancer J Clin       Date:  2016-11-29       Impact factor: 508.702

2.  LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer.

Authors:  Yang Liu; Yanling Yang; Lei Li; Yuan Liu; Peng Geng; Guilin Li; Hongjuan Song
Journal:  Biochem Cell Biol       Date:  2017-09-20       Impact factor: 3.626

3.  MicroRNA regulation of transthyretin in trophoblast biofunction and preeclampsia.

Authors:  Guangming Cao; Ran Cui; Chongdong Liu; Zhenyu Zhang
Journal:  Arch Biochem Biophys       Date:  2019-10-05       Impact factor: 4.013

4.  Identification of Potential Long Noncoding RNA Biomarker of Mercury Compounds in Zebrafish Embryos.

Authors:  Mengxi Cao; Fei Song; Xue Yang; Lei Peng; Yang Cheng; Qi Zheng; Yong Liang; Chang Wang
Journal:  Chem Res Toxicol       Date:  2019-04-04       Impact factor: 3.739

5.  Etiology of Laryngeal Squamous Cell Carcinoma: Study of 50 Cases in Mymensingh Medical College Hospital.

Authors:  J A Khan; M A Siddque; M N Haque; S C Kundu; M U Ahmed; A S Bhuiyan
Journal:  Mymensingh Med J       Date:  2015-07

6.  Circ_0067934 correlates with poor prognosis and promotes laryngeal squamous cell cancer progression by sponging miR-1324.

Authors:  Y-L Chu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-04       Impact factor: 3.507

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

8.  Effects of S‑adenosyl‑L‑methionine on the invasion and migration of head and neck squamous cancer cells and analysis of the underlying mechanisms.

Authors:  Laura Mosca; Michele Minopoli; Martina Pagano; Francesca Vitiello; Maria Vincenza Carriero; Giovanna Cacciapuoti; Marina Porcelli
Journal:  Int J Oncol       Date:  2020-03-12       Impact factor: 5.650

9.  FADS1 promotes the progression of laryngeal squamous cell carcinoma through activating AKT/mTOR signaling.

Authors:  Rui Zhao; Linli Tian; Bo Zhao; Yanan Sun; Jing Cao; Kexin Chen; Fengqing Li; Minghua Li; Desi Shang; Ming Liu
Journal:  Cell Death Dis       Date:  2020-04-24       Impact factor: 8.469

10.  Genetic polymorphisms as non-modifiable susceptibility factors to laryngeal cancer.

Authors:  Paula Escalante; Tamara Barría; Miguel Cancino; Maritza Rahal; Leslie Cerpa; Christopher Sandoval; Sebastian Molina-Mellico; Marcelo Suárez; Matias Martínez; Dante Daniel Cáceres; Luis Abel Quiñones; Nelson Miguel Varela
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

View more
  1 in total

Review 1.  Potentials of lncRNA-miRNA-mRNA networks as biomarkers for laryngeal squamous cell carcinoma.

Authors:  Yan Lv; Yanhua Wang; Zhikai Zhang
Journal:  Hum Cell       Date:  2022-10-01       Impact factor: 4.374

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.